Skip to main content
. Author manuscript; available in PMC: 2015 Apr 7.
Published in final edited form as: Thromb Res. 2012 Sep 7;130(6):942–947. doi: 10.1016/j.thromres.2012.08.300

Table 2.

Repeat length frequency by race

Whites Blacks

Repeat length Case n
(%)
Control
n (%)
p-value Case
n (%)
Control
n (%)
p-value
A. All VTE
S/S 47 (11.3) 58 (11.4) p=0.49 26 (5.9) 14 (3.2) p=0.02
S/M 170 (40.9) 212 (41.5) 72 (16.4) 86 (19.4)
S/L 9 (2.2) 21 (4.1) 49 (11.1) 43 (9.7)
M/M 161 (38.7) 191 (37.4) 91 (20.7) 112 (25.3)
M/L 29 (7.0) 28 (5.5) 131 (29.8) 143 (32.3)
L/L 0 1 (0.2) 71 (16.1) 45 (10.2)
B. Idiopathic VTE
S/S 17 (10.7) 58 (11.4) p=0.40 7 (3.8) 14 (3.2) p=0.78
S/M 71 (44.7) 212 (41.5) 34 (18.3) 86 (19.4)
S/L 1 (0.6) 21 (4.1) 20 (31.8) 43 (9.7)
M/M 61 (38.4) 191 (37.4) 43 (23.1) 112 (25.3)
M/L 9 (24.3) 28 (5.5) 56 (30.1) 143 (32.3)
L/L 0 1 (0.2) 26 (14.0) 45 (10.2)
C. Provoked VTE
S/S 30 (11.7) 58 (11.4) p=0.72 19 (7.5) 14 (3.2) p=0.002
S/M 99 (38.5) 212 (41.5) 38 (15.0) 86 (19.4)
S/L 8 (3.1) 21 (4.1) 29 (11.4) 43 (9.7)
M/M 100 (38.9) 191 (37.4) 48 (18.9) 112 (25.3)
M/L 20 (7.8) 28 (5.5) 75 (29.5) 143 (32.3)
L/L 0 1 (0.2) 45 (17.7) 45 (10.2)
D. First event
S/S 36 (11.4) 58 (11.4) p=0.59 23 (6.5) 14 (3.2) p=0.09
S/M 134 (42.5) 212 (41.5) 58 (16.4) 86 (19.4)
S/L 6 (22.2) 21 (4.1) 42 (11.9) 43 (9.7)
M/M 120 (38.1) 191 (37.4) 78 (22.1) 112 (25.3)
M/L 19 (6.0) 28 (5.5) 105 (29.8) 143 (32.3)
L/L 0 1 (0.2) 47 (13.3) 45 (10.2)
E. Recurrent VTE
S/S 11 (10.9) 58 (11.4) p=0.54 3 (3.5) 14 (3.2) p=0.0008
S/M 36 (35.6) 212 (41.5) 14 (16.1) 86 (19.4)
S/L 3 (3.0) 21 (4.1) 7 (8.1) 43 (9.7)
M/M 41 (40.6) 191 (37.4) 13 (14.9) 112 (25.3)
M/L 10 (9.9) 28 (5.5) 26 (29.9) 143 (32.3)
L/L 0 1 (0.2) 24 (27.6) 45 (10.2)

‘S’ is ≤25, ‘M’ is 26–33, and ‘L’ is ≥34.